Word: arcs
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...many challenges in journalism is turning out serious articles about celebrities who say they served in Joan of Arc's army or strolled through Iran with Jesus Christ. "Free spirit," "flamboyant" and "controversial" are not really up to the task. In a profile of a well- known woman who insists that she has lived several times before, one journalese speaker came up with this deft line: "More than most people on this earth, she has found spiritual answers." In crime journalese, the top thug in any urban area is always referred to as a "reputed Mafia chieftain" and generally depicted...
...traffic for the shooting of a promotional film to aid Paris' bid for the 1992 Olympic Games. As the cameras rolled and 1976 Olympic Gold Medal Hurdler Guy Drut ran, torch in hand, up the deserted avenue, a blue, single-engine Rallye-Club suddenly zoomed in over the Arc de Triomphe and put down in a perfect landing...
...theguiding hands of the faculty. Will any of us everforget John Finley '28 in his waltz across thestage as he described Agamemnon, (he laterdescribed an Eliot House senior as a cross betweenAchilles and Harry Truman), pivoting as he reachedstage end and swirling the cord of his microphonein a deft arc...
...cutting edge of Hirsch and Groopman's research. They are azidothymidine (AZT), a synthetic drug that was originally designed to combat cancer, and alpha interferon, a relatively new, genetically-engineered substance. Hirsch has just concluded a two-year placebo-controlled, double-blind study of 24 AIDS and ARC patients treated with the interferon, whose results will be revealed in June. In addition, both Hirsch and Groopman are participating in a nation-wide study of AZT in AIDS and ARC patients. Hirsch has already enrolled more than 100 patients, while Groopman is in the process of selecting...
...problems plague the researchers in their quest for an effective and non-toxic anti-viral drug--some of them not involving science. Groopman has encountered peculiar problems in the AZT study. "There is tremendous political pressure," Groopman says. He only has room for 20 patients while 60 AIDS and ARC patients want to take part in the experiment. So he will choose patients only on a "first-come, first serve basis...